Climb Bio, Inc. (CLYM) Reports Q3 Loss of $0.13

November 15, 2024 12:59 AM EST

Climb Bio, Inc. (NASDAQ: CLYM) reported Q3 EPS of ($0.13), versus $0.00 reported last year.

For earnings history and earnings-related data on Climb Bio, Inc. (CLYM) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK